POON CHRISTINE A sold REGN

November 2, 2026 · Form 4 insider transaction

POON CHRISTINE A sold 201 shares of Regeneron Pharmaceuticals, Inc. at $971.31 per share, a transaction worth $195.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
201
Price
$971.31
Total value
$195.2K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 2, 2026
Filing dateNovember 4, 2026
Shares owned after5,219
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents volume-weighted average price of sales of 201 shares of Company stock on November 2, 2026 at prices ranging from $971.16 to $971.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.

View the original Form 4 on SEC EDGAR
POON CHRISTINE A sold REGN: November 2, 2026 | Insider Trading Screener